Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS.
area of the pons
brain measures
fragile X-associated tremor/ataxia syndrome
lipids
metabolic biomarkers
premutation carriers
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2021
2021
Historique:
received:
06
04
2021
accepted:
21
07
2021
entrez:
6
9
2021
pubmed:
7
9
2021
medline:
7
9
2021
Statut:
epublish
Résumé
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late adult-onset neurodegenerative disorder that affects movement and cognition in male and female carriers of a premutation allele (55-200 CGG repeats; PM) in the fragile X mental retardation (
Identifiants
pubmed: 34483988
doi: 10.3389/fpsyt.2021.691717
pmc: PMC8415564
doi:
Types de publication
Journal Article
Langues
eng
Pagination
691717Subventions
Organisme : NIMH NIH HHS
ID : R01 MH078041
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110100
Pays : United States
Informations de copyright
Copyright © 2021 Zafarullah, Durbin-Johnson, Fourie, Hessl, Rivera and Tassone.
Déclaration de conflit d'intérêts
DH has received funding from Novartis, Roche, Seaside Therapeutics LLC and Marinus Pharmaceuticals, Inc. for designing Fragile X clinical Trials. FT has received funding from Azrieli Foundation, Zynerba and Asuragen, Inc. for studies in Fragile X syndrome. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Med. 2014 Apr;20(4):415-8
pubmed: 24608097
AJNR Am J Neuroradiol. 2014 Nov-Dec;35(11):2099-105
pubmed: 24994832
Nat Rev Neurol. 2016 Jul;12(7):403-12
pubmed: 27340021
Hum Mol Genet. 2019 Mar 15;28(6):980-991
pubmed: 30476102
J Clin Psychiatry. 2006 Jan;67(1):87-94
pubmed: 16426093
Transl Psychiatry. 2013 Apr 09;3:e244
pubmed: 23571809
J Alzheimers Dis. 2017;60(3):809-817
pubmed: 27911300
Ann Neurol. 1999 Feb;45(2):265-9
pubmed: 9989633
Methods Mol Biol. 2019;1942:173-189
pubmed: 30900185
J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1329-1338
pubmed: 32928939
J Neurochem. 2017 Sep;142(5):756-766
pubmed: 28628213
J Cereb Blood Flow Metab. 2013 Oct;33(10):1493-9
pubmed: 23921897
Front Neurosci. 2018 Oct 25;12:784
pubmed: 30410433
Radiology. 2008 Jan;246(1):214-21
pubmed: 17991785
J Mol Diagn. 2008 Jan;10(1):43-9
pubmed: 18165273
Nat Rev Neurosci. 2009 Mar;10(3):211-23
pubmed: 19190638
Sci Rep. 2017 Oct 25;7(1):14038
pubmed: 29070876
Alzheimers Dement. 2017 Mar;13(3):236-246
pubmed: 27513978
J Proteome Res. 2018 Jul 6;17(7):2460-2469
pubmed: 29762036
Front Neurosci. 2018 Jun 25;12:379
pubmed: 29988561
Eur J Radiol. 2004 Sep;51(3):223-33
pubmed: 15294329
FASEB J. 2016 Oct;30(10):3334-3351
pubmed: 27335370
PLoS One. 2013 Oct 22;8(10):e77629
pubmed: 24167579
Neuroimage. 2009 Jul 1;46(3):677-82
pubmed: 19264138
Front Neurol. 2011 Jul 11;2:42
pubmed: 21808630
PLoS One. 2013 Sep 18;8(9):e73094
pubmed: 24058461
Biomark Med. 2014;8(9):1151-69
pubmed: 25402585
Adv Drug Deliv Rev. 2020;159:232-244
pubmed: 32360155
J Neurol. 2019 Apr;266(4):1036-1045
pubmed: 30460448
J Parkinsons Dis. 2014;4(3):549-60
pubmed: 24927756
Neurology. 2012 Oct 30;79(18):1898-907
pubmed: 23077007
Front Neurol. 2020 May 21;11:437
pubmed: 32528400
Anal Chem. 2009 Aug 15;81(16):6656-67
pubmed: 19624122
Arch Neurol. 2006 Jan;63(1):81-6
pubmed: 16401739
Radiology. 2006 Jun;239(3):825-30
pubmed: 16714464
Genome Med. 2012 Dec 21;4(12):100
pubmed: 23259642
Metallomics. 2015 Feb;7(2):363-70
pubmed: 25599126
Front Hum Neurosci. 2018 Jun 04;12:226
pubmed: 29915533
JAMA. 2004 Jan 28;291(4):460-9
pubmed: 14747503
J Clin Neurosci. 2016 Jan;23:162-164
pubmed: 26439425
Front Neurol. 2018 Jan 12;8:719
pubmed: 29375465
Mol Med. 2016 Oct;22:548-559
pubmed: 27385396
Nat Rev Neurosci. 2018 Jun;19(6):351-367
pubmed: 29740175
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
PLoS One. 2015 Mar 24;10(3):e0119452
pubmed: 25803028
Neural Regen Res. 2019 Mar;14(3):387-390
pubmed: 30539802
Biochim Biophys Acta Mol Basis Dis. 2018 Jul;1864(7):2430-2437
pubmed: 29684586
ACS Chem Biol. 2014 Sep 19;9(9):2032-48
pubmed: 24937102
Sci Rep. 2017 Aug 4;7(1):7328
pubmed: 28779141
J Neurol. 2008 Jan;255(1):144-6
pubmed: 18080849
Alzheimers Dement. 2017 Sep;13(9):965-984
pubmed: 28341160
Sci Rep. 2020 Jul 6;10(1):11099
pubmed: 32632326
Front Neurol. 2019 Mar 18;10:191
pubmed: 30936848
PLoS One. 2016 Jan 25;11(1):e0147129
pubmed: 26808974
Biochem J. 2016 Nov 1;473(21):3871-3888
pubmed: 27555610
PLoS One. 2013 May 20;8(5):e63644
pubmed: 23700429
Front Aging Neurosci. 2018 Sep 11;10:266
pubmed: 30254583
FASEB J. 2020 Dec;34(12):16676-16692
pubmed: 33131090
Front Mol Neurosci. 2016 Aug 12;9:71
pubmed: 27570505
Parkinsonism Relat Disord. 2014 Feb;20(2):222-5
pubmed: 24239142
Alzheimers Dement. 2018 Mar;14(3):318-329
pubmed: 29055815
Nat Commun. 2020 Aug 11;11(1):4016
pubmed: 32782260
Nat Rev Neurosci. 2017 Mar 17;18(4):251-259
pubmed: 28303016
EMBO J. 2017 Jun 1;36(11):1474-1492
pubmed: 28438892
Mol Neurobiol. 2019 May;56(5):3702-3713
pubmed: 30187385
Oxid Med Cell Longev. 2019 May 9;2019:2105607
pubmed: 31210837
Curr Biol. 2012 Sep 11;22(17):R741-52
pubmed: 22975005
Neuroimage. 2005 Jul 1;26(3):912-21
pubmed: 15955501
Transl Neurodegener. 2017 Mar 28;6:8
pubmed: 28360997
Nat Rev Dis Primers. 2017 Sep 29;3:17065
pubmed: 28960184
Front Neurosci. 2018 Apr 17;12:249
pubmed: 29719499
Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536
pubmed: 30911576
Front Neurosci. 2018 Aug 30;12:612
pubmed: 30214392
J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):722-8
pubmed: 17353258
Clin Chem. 2010 Mar;56(3):399-408
pubmed: 20056738
Mol Neurodegener. 2019 Jan 11;14(1):3
pubmed: 30634989